DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma
about
Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined ApproachMetabolic profiles are principally different between cancers of the liver, pancreas and breast.The vitamin D system is deregulated in pancreatic diseasesSix1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression.A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinomaIdentifying molecular subtypes related to clinicopathologic factors in pancreatic cancerPrognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal AdenocarcinomaLoss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition.Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachoneDetecting discordance enrichment among a series of two-sample genome-wide expression data sets.Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone.Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas.Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer.SIRT6 Suppresses Pancreatic Cancer through Control of Lin28bCTEN prolongs signaling by EGFR through reducing its ligand-induced degradationLong noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193bIntegration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancerPregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival.High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer.Overexpression and biological function of IQGAP3 in human pancreatic cancer.Prognostic value of PDL1 expression in pancreatic cancerAdrenomedullin promotes the growth of pancreatic ductal adenocarcinoma through recruitment of myelomonocytic cells.Identification of molecular biomarkers for pancreatic cancer with mRMR shortest path methodA self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses.Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715.Functional modules analysis based on coexpression network in pancreatic ductal adenocarcinoma.StemChecker: a web-based tool to discover and explore stemness signatures in gene sets.Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragmentsIntegrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma.A 25-gene classifier predicts overall survival in resectable pancreatic cancer.Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer.MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.Clinicopathological examination of dipeptidase 1 expression in colorectal cancer.Splice variants as novel targets in pancreatic ductal adenocarcinoma.Differential protein profiling of renal cell carcinoma urinary exosomes.Identification of novel therapeutic target genes and pathway in pancreatic cancer by integrative analysis.Identification of genes and candidate agents associated with pancreatic cancer.
P2860
Q28550351-F916542A-4338-490B-BA13-16ABED8BF823Q34157807-3813DAE9-AAD3-4A3E-BCAD-3AC25C0BC5C5Q34440700-22B1B725-2097-4E97-A454-38B21586A5EFQ34634833-11EB09CB-0B59-4F9F-A31C-E705E649E884Q34941883-4C6D1F26-EBB5-4AD6-80DE-1E4BC01FBA93Q35005431-F570A0A9-B50A-487F-ACD4-984A2366B4A2Q35738659-A02A510E-B065-4A21-8F40-3AECD2A3F04EQ35941554-A435449B-8518-41D8-BCB0-3A62740133DEQ36146939-8874607D-F2C1-4D5C-86E9-0D7310BD9439Q36280853-9E392285-C81B-4A0D-86EB-FFBAD1684BF2Q36316513-D2357674-9BDC-4BC2-9BC9-A63416DA37D6Q36326330-EEE837C8-8290-4D6B-9FB8-A9BF10A2D270Q36369201-1A52B95D-8EE4-4616-A95E-E562C41EA627Q36545666-4C6C1EF3-5AD5-4555-9F5E-5FECBC8C5081Q36962652-A6D72EDE-6D35-46CE-BBB3-9FA0A3F28EE1Q36968417-020180B5-E7B4-4254-BB05-6F4F892393DCQ37100087-70AA3B77-1261-49CF-9482-E068BEA67CCEQ37100568-08DADA36-4B58-46CE-81DB-802CC728218CQ37185159-DA0EAF40-EA3F-4F36-855E-43DB84C13E85Q37427937-1DEF6042-283D-467C-9DFE-E7C592731ABDQ37519435-D42FB63E-F905-4CC3-9ED0-FAC62F3285E5Q37553772-E9BF6B46-F2ED-4F51-9D1A-4F49FA80EF9AQ37687595-61B8A0D9-4D63-4A59-95BA-09C82980B8B4Q37688192-0526DFDF-A602-45F4-94A4-9D6C9A06EC0BQ38726982-5F16A4A4-D145-4A4B-97FD-CE419F5935D2Q38863828-AFDBD8D7-41D4-490C-A964-D7A65FE6AB7CQ39025924-0254A7CD-F11E-407C-A1D8-018DC830F7CAQ39053663-54FBB7DC-425D-426E-969E-7B3204C865DEQ39321919-976C783D-B7F8-4271-A605-8EF8890A0F26Q40904780-57B2E825-D412-4207-B4D3-99677109FB2AQ41279583-2A033B67-6B45-4C79-B5FA-822B971F5F19Q41592795-23F48A90-F5A3-49AE-A571-55ED22E12A8BQ41711884-06D0694F-D3D3-4040-8C49-0102895CDDB2Q41852863-1954D06F-E00D-4530-AD30-3DDFC5205E6AQ42016960-D57D43F8-711C-42F5-A806-D8F336D2A2FAQ42117499-B04F27BD-3623-416B-9D0A-DCA2D00D01D8Q42216004-208F9B1F-1876-4F17-8F32-959E64E55A1FQ44639478-5A91C052-103E-479B-A1D4-10BAB4C1A81BQ45905331-9104956C-BEF2-4E55-870A-FE3F24359D6DQ47807955-40B892DB-3304-4E41-8082-503F63207FB1
P2860
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@ast
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@en
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@nl
type
label
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@ast
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@en
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@nl
prefLabel
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@ast
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@en
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@nl
P2093
P2860
P1433
P1476
DPEP1 inhibits tumor cell inva ...... ncreatic ductal adenocarcinoma
@en
P2093
Aaron Schetter
Anirban Maitra
B Michael Ghadimi
Curtis Lacy
Dong H Lee
Geng Zhang
H Richard Alexander
Harris G Yfantis
Jochen Gaedcke
Nader Hanna
P2860
P304
P356
10.1371/JOURNAL.PONE.0031507
P407
P577
2012-02-20T00:00:00Z